History of Acupuncture Research

This comprehensive review traces the fascinating trajectory of acupuncture research from its earliest scientific documentation in the 17th century to contemporary developments. Acupuncture, practiced in China for more than 3,000 years, began its Western scientific journey in 1683, when the Dutch physician Wilhelm Ten Rhijne published the first observations on the therapeutic use of needles in patients with arthritis in Japan. This early milestone launched a slow but steady evolution of scientific interest in the centuries-old practice. The 18th century saw the first systematic efforts to understand the mechanisms of acupuncture.

The Viennese physician Gerard van Swieten, in 1755, documented his observations on the physiological communication involved in pain relief through acupuncture. Later, in 1798, Roughment proposed that acupuncture worked as a form of counterirritation, sketching the first theoretical models to explain acupuncture analgesia. Technological innovation arrived in 1825, when Sarlandiere introduced electrical stimulation to needles, laying the groundwork for what we now know as electroacupuncture. Research developed in different directions in different countries.

In Japan, during the Meiji Restoration, scientists adopted a unique approach, attempting to analyze meridians and points through Western medical theory. Ohkubo Tekisai, in 1894, proposed that acupuncture was a stimulation of the nervous system, leading to the development of techniques focused on the sympathetic ganglia. Yoshio Nakatani revolutionized the field in 1950 with the discovery of galvanic points using electrodermal measurement technology, creating the Ryodoraku system that is still used today. Korea contributed a radical perspective through Kim Bongham, who in the 1960s claimed to have discovered the anatomical basis of the meridians, identifying special ducts and corpuscles he called the Bongham system.

Although initially overlooked due to lack of reproducibility, this theory has recently been revisited as the primo-vascular system. The crucial turning point came in 1971 with the famous report by James Reston in The New York Times about his experience with acupuncture in China, followed by President Nixon's visit. This event catalyzed unprecedented scientific interest in the United States and Europe. In 1972, the NIH awarded its first grant for acupuncture research, and in 1975, the first influential randomized controlled trial was published in The New England Journal of Medicine.

Basic research experienced revolutionary advances in the 1970s and 1980s. The discovery of endogenous opioids and the demonstration that naloxone could block acupuncture analgesia provided the first solid scientific evidence of the neurobiological mechanisms of acupuncture. The pioneering work of Professor Han Jisheng on neurotransmitters and the gate control theory of Melzack and Wall established enduring theoretical foundations. The contemporary era, initiated with the establishment of the World Federation of Acupuncture and Moxibustion Societies in 1987, has witnessed an explosion in high-quality research.

The 1997 NIH Consensus Statement represented official recognition of the efficacy of acupuncture for several conditions. Modern technologies have revolutionized our understanding of acupuncture mechanisms. Functional neuroimaging studies have revealed how acupuncture modulates specific neural networks, while omics techniques (genomics, proteomics, metabolomics) have provided insights into the molecular effects of acupuncture stimulation. The discovery of the role of adenosine in local acupuncture analgesia represented a significant advance in understanding peripheral mechanisms.

Currently, research has expanded well beyond analgesia to include oncology, cardiovascular disorders, and gastrointestinal and neurological problems. High-quality studies have demonstrated efficacy in chemotherapy-induced nausea, menopausal symptoms in breast cancer patients, and radiation-induced xerostomia. However, challenges persist, particularly in reconciling traditional individualization of treatment with the standardization required for rigorous clinical trials.